| NCT ID | NCT02983604 |
| Title | GS-5829 in Combination With Exemestane or Fulvestrant Comparing With Exemestane or Fulvestrant Alone in Women With Advanced Estrogen Receptor Positive HER2- Breast Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | yes |
| Sponsors | Gilead Sciences |
| Indications | |
| Therapies | |
| Age Groups: | senior adult |